Kiyozumi M, Inoue T, Kojima S, Hidaka S, Tsuruoka M
Department of School Health, Faculty of Education, Kumamoto University, Japan.
Toxicology. 1991 Mar 25;67(1):41-51. doi: 10.1016/0300-483x(91)90162-t.
Sodium N-benzyl-D-glucamine dithiocarbamate (BGD) was evaluated for its efficacy as an inhibitor of cis-diamminedichloroplatinum (DDP)-induced nephrotoxicity in a rat model. Treatment with 2.0 mmol/kg of BGD immediately after DDP injection effectively prevented nephrotoxic effects of DDP, but administration of BGD -1 or 1 h after DDP afforded a small protection. Concurrent treatment with 0.5 mmol/kg of BGD could not prevent renal damage. The platinum concentrations in liver and kidney were significantly decreased by BGD treatment. The antitumor efficacy of DDP in the Walker 256 carcinoma-bearing rats was not affected by administration of BGD (2.0 mmol/kg).
在大鼠模型中评估了N-苄基-D-葡糖胺二硫代氨基甲酸钠(BGD)作为顺二氯二氨铂(DDP)诱导的肾毒性抑制剂的功效。在注射DDP后立即用2.0 mmol/kg的BGD进行治疗可有效预防DDP的肾毒性作用,但在DDP注射后-1或1小时给予BGD则提供了较小的保护作用。同时用0.5 mmol/kg的BGD进行治疗不能预防肾损伤。BGD治疗可使肝脏和肾脏中的铂浓度显著降低。给予BGD(2.0 mmol/kg)不会影响DDP对携带Walker 256癌的大鼠的抗肿瘤功效。